The 20 Best Prostate Cancer Doctors near San Francisco, CA

Hao Nguyen is a Urologist in San Francisco, California. Dr. Nguyen is rated as an Elite provider by MediFind in the treatment of Prostate Cancer. His top areas of expertise are Prostate Cancer, Familial Prostate Cancer, Urothelial Cancer, Prostatectomy, and Thrombectomy.

Eric Small is a Hematologist in San Francisco, California. Dr. Small is rated as an Elite provider by MediFind in the treatment of Prostate Cancer. His top areas of expertise are Prostate Cancer, Familial Prostate Cancer, Renal Cell Carcinoma (RCC), Orchiectomy, and Prostatectomy.

Terence Friedlander is a Hematologist in San Francisco, California. Dr. Friedlander is rated as an Elite provider by MediFind in the treatment of Prostate Cancer. His top areas of expertise are Familial Prostate Cancer, Prostate Cancer, Urothelial Cancer, Bladder Cancer, and Prostatectomy.

Katsuto Shinohara is a Urologist in San Francisco, California. Dr. Shinohara is rated as an Elite provider by MediFind in the treatment of Prostate Cancer. His top areas of expertise are Prostate Cancer, Familial Prostate Cancer, Enlarged Prostate (BPH), Malakoplakia, and Prostatectomy.

Matthew Cooperberg is a Urologist in San Francisco, California. Dr. Cooperberg is rated as an Elite provider by MediFind in the treatment of Prostate Cancer. His top areas of expertise are Prostate Cancer, Familial Prostate Cancer, Urinary Incontinence, Prostatectomy, and Orchiectomy.

Brian Grady is a Urologist in San Francisco, California. Dr. Grady is rated as a Distinguished provider by MediFind in the treatment of Prostate Cancer. His top areas of expertise are Enlarged Prostate (BPH), Familial Prostate Cancer, Prostate Cancer, Ureteroscopy, and Prostatectomy. Dr. Grady is currently accepting new patients.

Laura Crocitto is a Urologist in San Francisco, California. Dr. Crocitto is rated as an Advanced provider by MediFind in the treatment of Prostate Cancer. Her top areas of expertise are Prostate Cancer, Familial Prostate Cancer, Bladder Cancer, Cystectomy, and Prostatectomy.

Dr. I-Chow Hsu, who goes by Joe, is a radiation oncologist with expertise in brachytherapy, a form of radiation therapy in which the source of radiation is placed inside the body to directly target a cancer site. (This treatment is often used for prostate cancer that has not spread beyond the gland.) Hsu has special research interests in using brachytherapy and hyperthermia (killing cancer cells through exposure to high temperatures) to treat cancers of the genital and urinary organs, as well as gynecologic cancers. Hsu earned his medical degree at the Johns Hopkins School of Medicine. He completed a residency in radiation oncology at NewYork-Presbyterian Hospital and Columbia University. Hsu is a fellow of the American College of Radiology and American Society for Radiation Oncology. He is an active member of numerous professional societies, including the American Society for Radiation Oncology, American Brachytherapy Society and Society for Thermal Medicine. He chairs the Radiation Therapy Oncology Group's committee on brachytherapy. Dr. Hsu is rated as a Distinguished provider by MediFind in the treatment of Prostate Cancer. His top areas of expertise are Neuroendocrine Carcinoma of the Cervix, Cervical Cancer, Prostate Cancer, and Familial Prostate Cancer.

Dr. Peter Carroll is a surgeon specializing in urological oncology. He is internationally known for his expertise in managing patients with cancers of the urinary system. In research, Carroll's areas of interest include early detection and patient-centered management of urological cancers, most notably prostate cancer. He is principal investigator or co-investigator of many studies that received peer-reviewed research grants as well as author or co-author of more than 700 publications. Carroll earned his medical degree from Georgetown University School of Medicine, graduating with honors. He completed training in general surgery and a residency in urology at UCSF. He completed a fellowship in urologic oncology at Memorial Sloan Kettering Cancer Center before returning to UCSF. He also has a master of public health degree from the University of California, Berkeley. At UCSF, he holds both the Ken and Donna Derr-Chevron and Taube Family distinguished professorships. Dr. Carroll is rated as a Distinguished provider by MediFind in the treatment of Prostate Cancer. His top areas of expertise are Familial Prostate Cancer, Prostate Cancer, Bladder Cancer, Reconstructive Urology Surgery, and Hernia Surgery.

Dr. Alexander Gottschalk, an expert in radiation treatment, specializes in caring for patients with lung cancer, prostate cancer and sarcoma. He directs UCSF's program in CyberKnife surgery, in which a flexible robotic arm is used to precisely deliver high doses of radiation. He uses CyberKnife and other forms of stereotactic body radiation therapy to treat cancers of the lung or prostate, as well as cancer that has spread to the bones or lymph nodes. Gottschalk earned both his medical degree and doctorate in pathology at the University of Chicago. He completed a residency in radiation oncology at UCSF. Gottschalk has received numerous awards and research grants, including a research service award and a medical scientist fellowship from the National Institutes of Health, a clinical research grant from the UCSF Helen Diller Family Comprehensive Cancer Center, a scholar award from the Radiological Society of North America and a junior faculty award from the American Society for Radiation Oncology. Dr. Gottschalk is rated as a Distinguished provider by MediFind in the treatment of Prostate Cancer. His top areas of expertise are Prostate Cancer, Pleuropulmonary Blastoma, Lung Cancer, Familial Prostate Cancer, and Prostatectomy.

Dr. Maxwell Meng is a surgeon specializing in urologic cancers and laparoscopy. His interests in patient care include diagnosing and managing cancers of the genital and urinary organs, as well as minimally invasive treatments of both benign and malignant diseases. He is experienced in robotic surgery. Meng is active in research to develop new treatment technologies. Meng earned his medical degree at Johns Hopkins School of Medicine. He completed general surgery and urology training at UCSF, where he also completed fellowships in urologic oncology and minimally invasive surgery. Dr. Meng is rated as a Distinguished provider by MediFind in the treatment of Prostate Cancer. His top areas of expertise are Bladder Cancer, Renal Cell Carcinoma (RCC), Urothelial Cancer, Nephrectomy, and Reconstructive Urology Surgery.

Dr. Sima Porten is a specialist in cancers of the genital and urinary organs. She is a member of the urologic oncology team at the UCSF Helen Diller Family Comprehensive Cancer Center. Her clinical interests include the diagnosis and treatment of genitourinary cancer, particularly bladder cancer, upper tract urothelial cancer, kidney cancer and high-risk prostate cancer. Porten's research focuses mainly on the diagnosis and management of urothelial carcinoma, a cancer involving parts of the kidney, bladder and ureter (the tube connecting each kidney to the bladder). In studying the biologic or genetic basis of urothelial carcinoma, she hopes to develop new tests and treatments to bring personalized medicine to patients with bladder cancer. Porten received her undergraduate, medical and master of public health degrees from Northwestern University. During medical school, she was inducted into the Alpha Omega Alpha Honor Medical Society and also completed a fellowship through the Howard Hughes Medical Institute–National Institutes of Health Research Scholars Program. She then completed her urology residency training at UCSF, where she received the Julius R. Krevans Award for Clinical Excellence. During her training in urologic oncology at the University of Texas MD Anderson Cancer Center, she was awarded a John Quale Travel Fellowship for her research in bladder cancer. Porten is an active member of the American Urological Association, American Society of Clinical Oncology, Society of Women in Urology and Society of Urologic Oncology. Dr. Porten is rated as a Distinguished provider by MediFind in the treatment of Prostate Cancer. Her top areas of expertise are Bladder Cancer, Urothelial Cancer, Non-Muscle Invasive Bladder Cancer, Cystectomy, and Nephrectomy.

Dr. Rahul Aggarwal is a specialist in cancers of the genital and urinary organs. He cares for patients at the UCSF Helen Diller Family Comprehensive Cancer Center. He also serves as director of the UCSF STAND (Supportive Therapy in Androgen Deprivation) Clinic, which provides comprehensive care to men who are receiving androgen deprivation therapy, hormone therapy for prostate cancer. As a member of the Developmental Therapeutics Genitourinary Cancer Program, Aggarwal enrolls patients with advanced solid tumor malignancies into early-phase clinical trials of novel targeted treatments. His research focuses on developing hormonal treatment strategies that reduce the toxicity of androgen deprivation therapy for men with advanced prostate cancer. He is also interested in developing new molecular imaging techniques that will help predict how advanced solid tumors will respond to treatment. Aggarwal earned his medical degree from the Northwestern University Feinberg School of Medicine. At UCSF, he completed an internship and residency in internal medicine, followed by a clinical fellowship in hematology and oncology. Aggarwal has also been a research fellow in developmental therapeutics at Genentech. He is a member of the American Society of Clinical Oncology (ASCO) and recipient of the ASCO/Conquer Cancer Foundation Young Investigator Award. Dr. Aggarwal is rated as a Distinguished provider by MediFind in the treatment of Prostate Cancer. His top areas of expertise are Prostate Cancer, Familial Prostate Cancer, Melanoma of the Eye, and Muscle Invasive Bladder Cancer.

Dr. Vadim S. Koshkin is a genitourinary oncologist who specializes in caring for adults with bladder, prostate, kidney and testicular cancers. His personal enthusiasm for travel informs his approach to care, as he likes to hear about where his patients come from in order to better understand who they are. In his research, Koshkin designs and carries out clinical trials of treatments for bladder and prostate cancers. He has a particular focus on the role of immunotherapy, or treatments that stimulate a patient's own immune system to help fight cancer. He also studies targeted treatments that are aimed against specific mutations in the DNA of tumor cells, which make these tumors more vulnerable to particular drugs. This allows for the delivery of personalized treatment based on individual characteristics of patients and their tumors. After earning his medical degree at the University of Chicago Pritzker School of Medicine, Koshkin completed a residency in internal medicine at the University of Michigan. He then completed a fellowship in hematology and oncology at the Cleveland Clinic. He belongs to the American Society of Clinical Oncology, American Association for Cancer Research and Bladder Cancer Advocacy Network. A history and trivia buff, Koshkin loves to read. He also follows soccer and Chicago sports teams in his free time. Dr. Koshkin is rated as a Distinguished provider by MediFind in the treatment of Prostate Cancer. His top areas of expertise are Urothelial Cancer, Bladder Cancer, Renal Cell Carcinoma (RCC), Non-Muscle Invasive Bladder Cancer, and Lymphadenectomy.

Dr. Jonathan Chou cares for patients with cancers affecting the genital and urinary organs, including prostate, bladder, kidney and testicular cancers. Rather than taking a one-size-fits-all approach, he applies precision medicine techniques – which take into account an individual's genes, lifestyle and other factors – to treatment, with targeted therapies and immunotherapy among the components in his oncology arsenal. Chou is a physician-scientist, a doctor particularly focused on medical research. His areas of research include developing more precise ways to treat cancer. He studies molecular subtypes of cancer and uses genome-editing technology to engineer cell models in the lab, seeking to understand how specific mutations affect cancer properties. He also uses genetic and drug screening to find new ways of killing cancer cells, and incorporates patient-derived tumor xenografts (models in which cells from a patient’s tumor are implanted in an animal) to investigate drug resistance. Chou earned his medical degree and a doctorate in biomedical sciences from UCSF. He also completed a residency in internal medicine and a fellowship in oncology at UCSF. In his free time, Chou loves trying new bakeries and restaurants around San Francisco. He and his wife enjoy going to the beach with their young daughter and their Aussiedoodle. Dr. Chou is rated as a Distinguished provider by MediFind in the treatment of Prostate Cancer. His top areas of expertise are Familial Prostate Cancer, Prostate Cancer, Urothelial Cancer, and Bladder Cancer.

caring, good listener, dedicated, intelligent, compassionate, committed, healing and reassuring. Dr. Rector is rated as an Advanced provider by MediFind in the treatment of Prostate Cancer. His top areas of expertise are Enlarged Prostate (BPH), Familial Prostate Cancer, Prostate Cancer, Ureteroscopy, and Prostatectomy.

Dr. Benjamin Breyer is a urologic surgeon who specializes in complex urethral and penile reconstruction, male incontinence, male fistulas and surgery for erectile dysfunction. Breyer's research has been federally supported and focuses on the epidemiology (the study of which populations are affected by diseases, factors affecting outcomes and related matters) of sexual dysfunction and lower urinary tract disorders. He also studies urologic trauma and surgical repair of the urinary tract. He has authored or co-authored more than 350 articles and book chapters. Breyer earned his medical degree from the Pritzker School of Medicine at the University of Chicago. At UCSF, he completed a residency in urology, followed by a fellowship in male genitourinary reconstruction and trauma. He also earned his master of advanced study degree in clinical research at UCSF. Dr. Breyer is rated as a Distinguished provider by MediFind in the treatment of Prostate Cancer. His top areas of expertise are Urethral Stricture, Urinary Incontinence, Stress Urinary Incontinence, Reconstructive Urology Surgery, and Prostatectomy.

Ira Sharlip is a Urologist in San Francisco, California. Dr. Sharlip is rated as an Advanced provider by MediFind in the treatment of Prostate Cancer. His top areas of expertise are Premature Ejaculation, Enlarged Prostate (BPH), Urinary Tract Infection in Children, Prostatectomy, and Vasectomy. Dr. Sharlip is currently accepting new patients.

Donald Abrams is an Oncologist in San Francisco, California. Dr. Abrams is rated as an Advanced provider by MediFind in the treatment of Prostate Cancer. His top areas of expertise are Angiosarcoma, Small Cell Lung Cancer (SCLC), Inflammatory Breast Cancer, and Familial Prostate Cancer.

David Kornguth is a Radiation Oncologist in San Francisco, California. Dr. Kornguth is rated as a Distinguished provider by MediFind in the treatment of Prostate Cancer. His top areas of expertise are Prostate Cancer, Familial Prostate Cancer, Upper Tract Urothelial Carcinoma (UTUC), and Non-Muscle Invasive Bladder Cancer.